Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cell-based quadrivalent influenza vaccine vs non-influenza comparator in children and adolescents
2016-002883-15Phase 3Completed
- Sponsor
- CSL Seqirus
- Start
- May 2017
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of influenza vaccine surface antigen inactivated prepared in cell cultures in influenza (2 arms), sponsored by CSL Seqirus. Started May 2017; status: completed.
02
Drugs
influenza vaccine surface antigen inactivated prepared in cell cultures
03
Conditions
influenza
Beyond the preview
Go deeper on 2016-002883-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002883-15.